Search results
Vilya Announces New Publication in Science Validating Foundational Approach to Design of Novel...
Morningstar· 4 days agoVILYA, Inc. (Vilya), a biotechnology company creating a new class of medicines that precisely targets disease biology, today announced the publication of a new study in Science that validates ...
Texas Biomed researching vaccines and treatments for highly pathogenic avian influenza
Newswise· 4 days agoResearchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly pathogenic avian influenza, including H5N1 strains ...